The Hsp90 inhibitor 17-(allylamino)-17-demethoxygeldanamycin increases cisplatin antitumor activity by inducing p53-mediated apoptosis in head and neck cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Hsp90 inhibitor 17-(allylamino)-17-demethoxygeldanamycin increases cisplatin antitumor activity by inducing p53-mediated apoptosis in head and neck cancer
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 4, Issue 12, Pages e956-e956
Publisher
Springer Nature
Online
2013-12-13
DOI
10.1038/cddis.2013.488
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Small-Molecule p53 Activator Induces Apoptosis through Inhibiting MDMX Expression in Breast Cancer Cells
- (2015) Hongbo Wang et al. NEOPLASIA
- Targeting p53 by small molecules in hematological malignancies
- (2013) Manujendra N Saha et al. Journal of Hematology & Oncology
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Blockade of Hsp90 by 17AAG antagonizes MDMX and synergizes with Nutlin to induce p53-mediated apoptosis in solid tumors
- (2011) A V Vaseva et al. Cell Death & Disease
- Nutlin-3, the small-molecule inhibitor of MDM2, promotes senescence and radiosensitises laryngeal carcinoma cells harbouring wild-type p53
- (2010) A K Arya et al. BRITISH JOURNAL OF CANCER
- A Stapled p53 Helix Overcomes HDMX-Mediated Suppression of p53
- (2010) Federico Bernal et al. CANCER CELL
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Identification and Characterization of the First Small Molecule Inhibitor of MDMX
- (2010) Damon Reed et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MDM2 Mediates Ubiquitination and Degradation of Activating Transcription Factor 3
- (2010) Pingli Mo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Contrasting Effects of Nutlin-3 on TRAIL- and Docetaxel-Induced Apoptosis Due to Upregulation of TRAIL-R2 and Mcl-1 in Human Melanoma Cells
- (2010) H.-Y. Tseng et al. MOLECULAR CANCER THERAPEUTICS
- A Small-Molecule Inhibitor of MDMX Activates p53 and Induces Apoptosis
- (2010) H. Wang et al. MOLECULAR CANCER THERAPEUTICS
- p53-Reactivating small molecules induce apoptosis and enhance chemotherapeutic cytotoxicity in head and neck squamous cell carcinoma
- (2010) Jong-Lyel Roh et al. ORAL ONCOLOGY
- Restoration of p53 Pathway by Nutlin-3 Induces Cell Cycle Arrest and Apoptosis in Human Rhabdomyosarcoma Cells
- (2009) M. Miyachi et al. CLINICAL CANCER RESEARCH
- MDM4 (MDMX) localizes at the mitochondria and facilitates the p53-mediated intrinsic-apoptotic pathway
- (2009) Francesca Mancini et al. EMBO JOURNAL
- Pharmacologic p53 Activation Blocks Cell Cycle Progression but Fails to Induce Senescence in Epithelial Cancer Cells
- (2009) B. Huang et al. MOLECULAR CANCER RESEARCH
- Targeting Mdm2 and Mdmx in Cancer Therapy: Better Living through Medicinal Chemistry?
- (2009) Mark Wade et al. MOLECULAR CANCER RESEARCH
- Inhibition of Hsp90 via 17-DMAG induces apoptosis in a p53-dependent manner to prevent medulloblastoma
- (2009) O. Ayrault et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular Pathology of Head and Neck Cancer: Implications for Diagnosis, Prognosis, and Treatment
- (2008) Sara I. Pai et al. Annual Review of Pathology-Mechanisms of Disease
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More